- $179.99bn
- $208.59bn
- $54.23bn
- 74
- 34
- 91
- 73
2019 December 28th | 2020 December 26th | 2021 December 25th | 2022 December 31st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 53 W | 52 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 71,965 | 77,867 | 79,024 | 63,054 | 54,228 |
Cost of Revenue | |||||
Gross Profit | 42,140 | 43,612 | 43,815 | 27,793 | 21,711 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 49,930 | 54,183 | 59,568 | 59,720 | 54,135 |
Operating Profit | 22,035 | 23,684 | 19,456 | 3,334 | 93 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 24,058 | 25,078 | 21,703 | 7,768 | 762 |
Provision for Income Taxes | |||||
Net Income After Taxes | 21,048 | 20,899 | 19,868 | 8,017 | 1,675 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 21,048 | 20,899 | 19,868 | 8,014 | 1,689 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 21,048 | 20,899 | 19,868 | 8,014 | 1,689 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.09 | 5.37 | 5.47 | 2.17 | 0.585 |
Dividends per Share |